{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T07:40:15Z","timestamp":1792309215317,"version":"4.4.0"},"reference-count":30,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:00Z","timestamp":1780099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Urologia"],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>To evaluate the long-term outcomes of selective trans-arterial embolization (SAE) in patients with giant (\u2a7e10\u2009cm in size) renal angiomyolipomas (AMLs) at our tertiary referral center.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and methods:<\/jats:title>\n                    <jats:p>This retrospective, single-center study included 44 patients who underwent SAE for AMLs of \u2a7e10\u2009cm size between July 2018 and June 2024. Collected data included demographics, tumor characteristics, clinical symptoms, type of intervention, tumor size before and after embolization, and renal function. Outcomes assessed were tumor size reduction, preservation of renal function, reintervention rates during follow-up and complications following SAE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The study included 46 tumors in 44 patients. Mean patient age was 40.4\u2009years (range: 23\u201360), with 86.3% being females. Mean follow-up duration was 25.2\u2009months (range: 6\u201370\u2009months). Eleven patients (25%) were associated with TSC, and all were offered Everolimus postoperatively. The mean tumor size decreased significantly from 13.2\u2009\u00b1\u20093.12\u2009cm pre-embolization to 10.3\u2009\u00b1\u20092.45\u2009cm post-embolization (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.003). Renal function remained stable during follow-up, with no significant changes in serum creatinine (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.6) and eGFR (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.8). The overall success rate was 84.7%, with 13.6% experiencing re-intervention. Complications included post-embolization syndrome (43.1%) and allergic reactions (6.8%), while one patient required nephrectomy due to a perinephric abscess.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Selective Trans-arterial Embolization is a safe and effective treatment for giant renal AMLs, resulting in significant tumor size reduction, symptom relief, and preservation of renal function. It offers a minimally invasive alternative to traditional surgical approaches, particularly for patients with high surgical risk or those requiring nephron-sparing procedure.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/03915603261450679","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T14:46:56Z","timestamp":1780152416000},"page":"659-668","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Long-term outcomes of selective arterial embolization in giant renal angiomyolipoma: A retrospective single-center study"],"prefix":"10.1177","volume":"93","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3353-9697","authenticated-orcid":false,"given":"Uday Pratap","family":"Singh","sequence":"first","affiliation":[{"name":"Department of Urology &amp; Renal Transplantation, Sanjay Gandhi Post-Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4079-6055","authenticated-orcid":false,"given":"Kunj B.","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Urology &amp; Renal Transplantation, Sanjay Gandhi Post-Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7208-7234","authenticated-orcid":false,"given":"Ashish","family":"Ranjan","sequence":"additional","affiliation":[{"name":"Department of Urology &amp; Renal Transplantation, Sanjay Gandhi Post-Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1840-7701","authenticated-orcid":false,"given":"Arpan","family":"Yadav","sequence":"additional","affiliation":[{"name":"Department of Urology &amp; Renal Transplantation, Sanjay Gandhi Post-Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanchit","family":"Rustagi","sequence":"additional","affiliation":[{"name":"Department of Urology &amp; Renal Transplantation, Sanjay Gandhi Post-Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjoy Kumar","family":"Sureka","sequence":"additional","affiliation":[{"name":"Department of Urology &amp; Renal Transplantation, Sanjay Gandhi Post-Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,5,30]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"crossref","unstructured":"Flum AS Hamoui N Said MA et al. Update on the diagnosis and management of renal angiomyolipoma. J Urol 2016; 195(4 Pt 1): 834\u2013846. https:\/\/doi.org\/10.1016\/j.juro.2015.07.126","DOI":"10.1016\/j.juro.2015.07.126"},{"key":"e_1_3_3_3_2","doi-asserted-by":"crossref","unstructured":"Jinzaki M Silverman SG Akita H et al. Renal angiomyolipoma: a radiological classification and update on recent developments in diagnosis and management. Abdom Imaging 2014; 39(3): 588\u2013604. https:\/\/doi.org\/10.1007\/s00261-014-0083-3","DOI":"10.1007\/s00261-014-0083-3"},{"key":"e_1_3_3_4_2","doi-asserted-by":"crossref","unstructured":"Curatolo P Bombardieri R Jozwiak S. Tuberous sclerosis. Lancet 2008; 372(9639): 657\u2013668. https:\/\/doi.org\/10.1016\/S0140-6736(08)61279-9","DOI":"10.1016\/S0140-6736(08)61279-9"},{"key":"e_1_3_3_5_2","doi-asserted-by":"crossref","unstructured":"Vos N Oyen R. Renal angiomyolipoma: the good the bad and the ugly. J Belg Soc Radiol 2018; 102(1): 41. https:\/\/doi.org\/10.5334\/jbsr.1536","DOI":"10.5334\/jbsr.1536"},{"key":"e_1_3_3_6_2","doi-asserted-by":"crossref","unstructured":"Wang C Yang M Tong X et al. Transarterial embolization for renal angiomyolipomas: a single centre experience in 79 patients. J Int Med Res 2017; 45(2): 706\u2013713. https:\/\/doi.org\/10.1177\/0300060516684251","DOI":"10.1177\/0300060516684251"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.carj.2018.01.002"},{"key":"e_1_3_3_8_2","doi-asserted-by":"crossref","unstructured":"Bissler JJ Kingswood JC Radzikowska E et al. Everolimus long-term use in patients with tuberous sclerosis complex: four-year update of the EXIST-2 study. PLoS One 2017; 12(8): e0180939. https:\/\/doi.org\/10.1371\/journal.pone.0180939","DOI":"10.1371\/journal.pone.0180939"},{"key":"e_1_3_3_9_2","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez-Pello S Hora M Kuusk T et al. Management of sporadic renal angiomyolipomas: a systematic review of available evidence to guide recommendations from the European Association of Urology Renal Cell Carcinoma guidelines panel. Eur Urol Oncol 2020; 3(1): 57\u201372. https:\/\/doi.org\/10.1016\/j.euo.2019.04.005","DOI":"10.1016\/j.euo.2019.04.005"},{"key":"e_1_3_3_10_2","doi-asserted-by":"crossref","unstructured":"Silvestri A Gavi F Sighinolfi MC et al. Management of small renal masses: literature and guidelines review. Int Braz J Urol 2025; 51(5): e20250203. https:\/\/doi.org\/10.1590\/S1677-5538.IBJU.2025.0203","DOI":"10.1590\/s1677-5538.ibju.2025.0203"},{"key":"e_1_3_3_11_2","doi-asserted-by":"crossref","unstructured":"Duan XH Zhang MF Ren JZ et al. Urgent transcatheter arterial embolization for the treatment of ruptured renal angiomyolipoma with spontaneous hemorrhage. Acta Radiol 2016; 57(11): 1360\u20131365. https:\/\/doi.org\/10.1177\/0284185115588125","DOI":"10.1177\/0284185115588125"},{"key":"e_1_3_3_12_2","doi-asserted-by":"crossref","unstructured":"Bishay VL Crino PB Wein AJ et al. Embolization of giant renal angiomyolipomas: technique and results. J Vasc Interv Radiol 2010; 21(1): 67\u201372. https:\/\/doi.org\/10.1016\/j.jvir.2009.09.020","DOI":"10.1016\/j.jvir.2009.09.020"},{"key":"e_1_3_3_13_2","doi-asserted-by":"crossref","unstructured":"El-Assmy A Abou-El-Ghar ME Mosbah A et al. Efficacy omplications and long-term outcomes of selective arterial embolization of symptomatic giant renal angiomyolipoma. Curr Urol 2011; 5: 179\u2013184. https:\/\/doi.org\/10.1159\/000327475","DOI":"10.1159\/000327475"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02923725"},{"key":"e_1_3_3_15_2","doi-asserted-by":"crossref","unstructured":"Chick CM Tan BS Cheng C et al. Long-term follow-up of the treatment of renal angiomyolipomas after selective arterial embolization with alcohol. BJU Int 2010; 105(3): 390\u2013394. https:\/\/doi.org\/10.1111\/j.1464-410X.2009.08813.x","DOI":"10.1111\/j.1464-410X.2009.08813.x"},{"key":"e_1_3_3_16_2","doi-asserted-by":"crossref","unstructured":"Soulen MC Faykus Mh Jr Shlansky-Goldberg RD et al. Elective embolization for prevention of hemorrhage from renal angiomyolipomas. J Vasc Interv Radiol 1994; 5(4): 587\u2013591. https:\/\/doi.org\/10.1016\/s1051-0443(94)71558-x","DOI":"10.1016\/S1051-0443(94)71558-X"},{"key":"e_1_3_3_17_2","doi-asserted-by":"crossref","unstructured":"Kessler OJ Gillon G Neuman M et al. Management of renal angiomyolipoma: analysis of 15 cases. Eur Urol 1998; 33(6): 572\u2013575. https:\/\/doi.org\/10.1159\/000019658","DOI":"10.1159\/000019658"},{"key":"e_1_3_3_18_2","doi-asserted-by":"crossref","unstructured":"Faddegon S So A. Treatment of angiomyolipoma at a tertiary care centre: the decision between surgery and angioembolization. Can Urol Assoc J 2011; 5(6): E138\u2013E141. https:\/\/doi.org\/10.5489\/cuaj.10028","DOI":"10.5489\/cuaj.10028"},{"key":"e_1_3_3_19_2","doi-asserted-by":"crossref","unstructured":"Boorjian SA Frank I Inman B et al. The role of partial nephrectomy for the management of sporadic renal angiomyolipoma. Urology 2007; 70(6): 1064\u20131068. https:\/\/doi.org\/10.1016\/j.urology.2007.07.045","DOI":"10.1016\/j.urology.2007.07.045"},{"key":"e_1_3_3_20_2","doi-asserted-by":"crossref","unstructured":"Seyam RM Bissada NK Kattan SA et al. Changing trends in presentation diagnosis and management of renal angiomyolipoma: comparison of sporadic and tuberous sclerosis complex-associated forms. Urology 2008; 72(5): 1077\u20131082. https:\/\/doi.org\/10.1016\/j.urology.2008.07.049","DOI":"10.1016\/j.urology.2008.07.049"},{"key":"e_1_3_3_21_2","doi-asserted-by":"crossref","unstructured":"Abouelkheir RT El-Ksas M Abdel Fattah S et al. Efficacy and safety of selective renal arterial embolization in renal angiomyolipoma: a prospective single-center study. Egypt J Radiol Nucl Med 2022; 53: 2\u20134. https:\/\/doi.org\/10.1186\/s43055-022-00848-3","DOI":"10.1186\/s43055-022-00848-3"},{"key":"e_1_3_3_22_2","doi-asserted-by":"crossref","unstructured":"Nozadze G Larsen SB Heerwagen S et al. Selective arterial embolization of renal angiomyolipomas: a 10-year experience. BJUI Compass 2022; 3(1): 86\u201392. https:\/\/doi.org\/10.1002\/bco2.107","DOI":"10.1002\/bco2.107"},{"key":"e_1_3_3_23_2","doi-asserted-by":"crossref","unstructured":"Bardin F Chevallier O Bertaut A et al. Selective arterial embolization of symptomatic and asymptomatic renal angiomyolipomas: a retrospective study of safety outcomes and tumor size reduction. Quant Imaging Med Surg 2017; 7(1): 8\u201323. https:\/\/doi.org\/10.21037\/qims.2017.01.02","DOI":"10.21037\/qims.2017.01.02"},{"key":"e_1_3_3_24_2","doi-asserted-by":"crossref","unstructured":"Prigent FV Guillen K Comby PO et al. Selective arterial embolization of renal angiomyolipomas with a N-butyl cyanoacrylate-lipiodol mixture: efficacy safety short- and Mid-Term outcomes. J Clin Med 2021; 10(18): 4062. https:\/\/doi.org\/10.3390\/jcm10184062 Published 2021 Sep 8.","DOI":"10.3390\/jcm10184062"},{"key":"e_1_3_3_25_2","doi-asserted-by":"crossref","unstructured":"Hocquelet A Cornelis F Le Bras Y et al. Long-term results of preventive embolization of renal angiomyolipomas: evaluation of predictive factors of volume decrease. Eur Radiol 2014; 24(8): 1785\u20131793. https:\/\/doi.org\/10.1007\/s00330-014-3244-4","DOI":"10.1007\/s00330-014-3244-4"},{"key":"e_1_3_3_26_2","doi-asserted-by":"crossref","unstructured":"Ramon J Rimon U Garniek A et al. Renal angiomyolipoma: long-term results following selective arterial embolization. Eur Urol 2009; 55(5): 1155\u20131161. https:\/\/doi.org\/10.1016\/j.eururo.2008.04.025","DOI":"10.1016\/j.eururo.2008.04.025"},{"key":"e_1_3_3_27_2","doi-asserted-by":"crossref","unstructured":"Murray TE Doyle F Lee M. Transarterial embolization of angiomyolipoma: a systematic review. J Urol 2015; 194(3): 635\u2013639. https:\/\/doi.org\/10.1016\/j.juro.2015.04.081","DOI":"10.1016\/j.juro.2015.04.081"},{"key":"e_1_3_3_28_2","doi-asserted-by":"crossref","unstructured":"Farg HM Elawdy MM Soliman KA et al. Predictors of renal angioembolization outcome: a retrospective analysis with 148 patients at a tertiary urology institute. Asian J Urol 2022; 9(2): 103\u2013108. https:\/\/doi.org\/10.1016\/j.ajur.2021.07.003","DOI":"10.1016\/j.ajur.2021.07.003"},{"key":"e_1_3_3_29_2","doi-asserted-by":"crossref","unstructured":"Ramakrishnan A Reilly D Sayre J et al. Predictors of hemorrhage and re-intervention in renal angiomyolipoma following transcatheter arterial embolization. J Clin Med 2025; 14(19): 6990. https:\/\/doi.org\/10.3390\/jcm14196990","DOI":"10.3390\/jcm14196990"},{"key":"e_1_3_3_30_2","doi-asserted-by":"crossref","unstructured":"Ewalt DH Diamond N Rees C et al. Long-term outcome of transcatheter embolization of renal angiomyolipomas due to tuberous sclerosis complex. J Urol 2005; 174(5): 1764\u20131766. https:\/\/doi.org\/10.1097\/01.ju.0000177497.31986.64","DOI":"10.1097\/01.ju.0000177497.31986.64"},{"key":"e_1_3_3_31_2","doi-asserted-by":"crossref","unstructured":"Ouzaid I Gabriel PE Lee B et al. Arterial embolization versus robotic partial nephrectomy for the treatment of renal angiomyolipomas. Int Braz J Urol 2025; 51(5): e20250163. https:\/\/doi.org\/10.1590\/S1677-5538.IBJU.2025.0163","DOI":"10.1590\/s1677-5538.ibju.2025.0163"}],"container-title":["Urologia Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/03915603261450679","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/03915603261450679","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/03915603261450679","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T07:06:40Z","timestamp":1792307200000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/03915603261450679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,30]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["10.1177\/03915603261450679"],"URL":"https:\/\/doi.org\/10.1177\/03915603261450679","relation":{},"ISSN":["0391-5603","1724-6075"],"issn-type":[{"value":"0391-5603","type":"print"},{"value":"1724-6075","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,30]]}}}